Jack A. Elias

About Jack A. Elias

Accolades

• 

  Pleural and Lung Cancer

• 

  Excellence in Research

• 

  Team Leader

• 

  30+ Years of Experience

Perhaps it’s why Elias was elected president of the Association of American Physicians, one of the most esteemed and selective medical societies.

Through his clinical research, Elias is heralded as a leading authority on lung diseases and lung injuries, including the topic of scarring that is often caused by the inhalation of asbestos fibers, which can lead to mesothelioma.

Elias has provided specific targets for pharmaceutical companies looking for therapies to help patients with asthma, emphysema, pulmonary fibrosis and other lung problems. His research groups have studied and developed genetic models that have translated well to human counterparts. His studies of molecular biology related to lung repair have been invaluable.

Esteemed Leader

Elias leads the Department of Internal Medicine, Yale’s largest department, with an estimated 350 full-time faculty members, $83 million in research funding and $45 million in clinical activity, as of 2006. He came to Yale in 1990 as a professor and chief of pulmonary and critical care medicine. He was appointed chairman of Internal Medicine in 2006.

As an author, Elias has been widely published, particularly in prestigious peer-review journals such as the Journal of Immunology, the Journal of Clinical Investigation and the Journal of Biological Chemistry. He also was co-author of “Fishman’s Manual of Pulmonary Diseases and Disorders.”

Elias received his undergraduate and medical degrees from the University of Pennsylvania, completing his residency at University of Pennsylvania Medical Center in 1979.

See More Top Mesothelioma Doctors

Quick Fact:

Dr. Elias has been appointed as Yale’s Waldemar von Zedtwitz Professor of Internal Medicine.

Publications

With over 100 publications in print, Elias is a widely respected author, appearing in journals such as the Clinical Immunology.